A detailed history of Precedent Wealth Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Precedent Wealth Partners, LLC holds 2,447 shares of ABT stock, worth $277,220. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,447
Previous 8,658 71.74%
Holding current value
$277,220
Previous $900 Million 68.99%
% of portfolio
0.09%
Previous 0.36%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$100.07 - $118.13 $621,534 - $733,705
-6,211 Reduced 71.74%
2,447 $279 Million
Q2 2024

Jul 23, 2024

BUY
$100.73 - $112.44 $81,087 - $90,514
805 Added 10.25%
8,658 $900 Million
Q1 2024

Apr 23, 2024

BUY
$109.52 - $120.96 $91,887 - $101,485
839 Added 11.96%
7,853 $893 Million
Q4 2023

Jan 18, 2024

BUY
$90.19 - $110.4 $632,592 - $774,345
7,014 New
7,014 $772 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $198B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Precedent Wealth Partners, LLC Portfolio

Follow Precedent Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Precedent Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Precedent Wealth Partners, LLC with notifications on news.